- Title: Subtitle
- PA-242 Impact of Immunomodulatory (IMiD) Containing Holding Therapy (HT) Regimens on Outcomes in Relapsed/Refractory (RRMM) Patients Receiving Chimeric Antigen Receptor–T Cell (CAR-T) Therapy
- Creators
- Veena B. KrishnanRishil ChopraHira ShaikhAbhiraj SaxenaMansi R. ShahJivtesh SinghPrerna MewawallaChandra KakaralaZena ChahineAbdullah M. KhanEmily CasteenBenjamin HaneWilliam MuehlebachMurtaza ShoaibLauren ScottAl-Ola AbdallahJordan SnyderJianzheng WuDinesh Pal MudaranthakamRatnayake Mudiyanselage Isuru RatnayakeCindy VargaShebli Atrash
- Resource Type
- Abstract
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.26(Suppl 2), pp.S182-S183
- DOI
- 10.1016/S2152-2650(26)03606-2
- ISSN
- 2152-2650
- Language
- English
- Date published
- 09/2026
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985236349302771
Abstract
PA-242 Impact of Immunomodulatory (IMiD) Containing Holding Therapy (HT) Regimens on Outcomes in Relapsed/Refractory (RRMM) Patients Receiving Chimeric Antigen Receptor–T Cell (CAR-T) Therapy
Clinical lymphoma, myeloma and leukemia, Vol.26(Suppl 2), pp.S182-S183
09/2026
DOI: 10.1016/S2152-2650(26)03606-2
Details
Metrics
1 Record Views